Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Obach
Pharmacokinetic and Pharmacodynamic Properties of a Long-Acting Formulation of the New Somatostatin Analogue, Lanreotide, in Normal Healthy Volunteers.
British Journal of Clinical Pharmacology
Pharmacology
Related publications
Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly
Journal of Endocrinological Investigation
Endocrinology
Metabolism
Diabetes
Effects of the Long-Acting Somatostatin Analogue Lanreotide Autogel on Glucose Tolerance and Insulin Resistance in Acromegaly
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children With Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia
Hormone Research in Paediatrics
Child Health
Endocrinology
Perinatology
Pediatrics
Metabolism
Diabetes
Population Pharmacokinetic-Pharmacodynamic Modeling of Captopril in Healthy Volunteers
Journal of Korean Society for Clinical Pharmacology and Therapeutics
Evaluation of Pharmacokinetic-Pharmacodynamic Relationship of Nitrazepam Using Computerized Eye Movement Analysis and Visual Analogue Scales in Healthy Japanese Volunteers.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
A Study of Potential Pharmacokinetic and Pharmacodynamic Interactions Between Dextromethorphan/Quinidine and Memantine in Healthy Volunteers
Clinical Drug Investigation
Medicine
Pharmacology
Comparative Pharmacokinetic and Pharmacodynamic Evaluation of Branded and Generic Formulations of Meloxicam in Healthy Male Volunteers
Therapeutics and Clinical Risk Management
Comparative Pharmacological and Pharmacokinetic Observations on Propranolol (Long Acting Formulation) and Bendrofluazide Administered Separately and Concurrently to Volunteers.
British Journal of Clinical Pharmacology
Pharmacology
Treatment of Patients With Pancreatic Endocrine Tumours Using a New Long-Acting Somatostatin Analogue Symptomatic and Peptide Responses.
Gut
Gastroenterology
